Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity

Journal of NeuroVirology

Volumn 4, Issue 4, 1998, Pages 387-393

  Bratanich, A C ^a   Liu, C ^a   McArthur, J C ^a,c   Fudyk, T ^a   Glass, J D ^a,b,d   Mittoo, S ^a   Klassen, G A ^a   Power, C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; HIV 1; Reverse transcriptase; Tat

Indexed keywords

POL PROTEIN; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; BRAIN INFECTION; DEMENTIA; GENETIC HETEROGENEITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION RATE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031825698     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114537     Document Type: Article

References (35)

1. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996). Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917 - 1921.
2. Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV-1 associated neurological diseases. J Biol Chem 272: 22385 - 22388.
3. Corboy JR, Buzy JM, Zink MC, Clements JE (1992). Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 1804 - 1807
4. Chao L (1994). Sex in RNA viruses The Evolutionary Biology of Viruses S. Morse (ed). Raven Press. New York NY.
5. Dreyer EB, Kaiser PK, Offerman JT, Lipton SA ((1990). HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364 - 367.
6. Gartner S, McDonald RA, Hunter EA, Bouwman F, Liu Y, Popovic M (1997). Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 primary isolates. J Hum Virol 1: 3 - 18.
7. Gaynor RB (1995). Regulation of HIV-1 gene expression by the transactivator protein tat. Curr Topic Microbiol Immunol 191: 52 - 77.
8. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755 - 762.
9. Green WC (1991). The molecular biology of human immunodeficiency virus type 1 infection. New Eng J Med 324: 308 - 337.
10. Hasenkrug KJ, Robertson SJ, Portis J, Machete F, Niche J, Chesebro B (1996). Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). J Virol 70: 4825 - 4828.
11. gag and env genes. J Virol 71: 1272 - 1280.
12. Kim T, Mudry RA, Rexrode CA, Pathak VK (1996). Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral infection. J Virol 70: 7594 - 7602.
13. Kumar S, Tamura K, Nei M (1993). MEGA: molecular evolutionary genetics analysis, version 1.01. Pennsylvania State University, University Park, PA 16802.
14. Li W-H (1997). Molecular evolution. Sinauer Associates, Sunderland MA.
15. Lipton SA and Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. New Eng J Med 332: 934 - 940.
16. Ma M, Geiger JD, Nath A (1997). Molecular determinants for cellular uptake of tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495 - 2499.
17. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995). Human immunodeficiency virus type 1 tat activates non-N-Methyl-D-Aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37: 373 - 380.
18. Mankowski JL, Flahery MT, Spelman JP, Hauer DA, Didier PJ, Martin Adee A, Murphey-Corb M, Kirstein LM, Munoz A, Clements JE, Zink MC (1997). Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 71: 6055 - 6060.
19. Mayne M, Bratanich AC, Chen P, Rana F, Nath A, Power C (1998). HIV-1 Tat molecular diversity and induction of TNF-α: implications for HIV-induced neurological disease. Neuroimmunomodulation (In press).
20. Movie GJ (1996). Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences. Drugs 52: 168 - 185.
21. Myers G, Wain-Hobson S, Korber B, Smith RF (1995). Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical biology and biophysics group T-10, Los Alamos, NM.
22. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD (1996). Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70: 1475 - 1480.
23. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643 - 4649.
24. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, Chesebro B (1995). Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol 202: 97 - 104.
25. Price RW, Brew BJ (1988). The AIDS dementia complex. J Infect Dis 158: 1079 - 1083.
26. Renjifo B, Borrero I, Essex M (1995). Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy. J Virol 69: 2611 - 2616.
27. Sei S, Saito K, Stewart SK, Crowley JS, Brouwers P, Kleiner DE, Katz DA, Pizzo PA, Heyes MP (1995). Increased human immunodeficiency virus type 1 (HIV-1) DNA content and quinolinic acid concentration in brain tissues from patients with HIV-encephalopathy. J Infect Dis 172: 638 - 647.
28. Sharpless NE, Wa OB, Verdin E, Kufta CV, Chen ISY, Dubois Dalcq M (1992). Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol 66: 2588 - 2593.
29. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/In situ hybridization and immunocytochemistry. Ann Neurol 39: 705 - 711.
30. Tyor WR, Glass JD, Griffin JW, Becker S, McArthur JC, Bezman L, Griffin DE (1992). Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349 - 360.
31. Van Hemert FJ, Berkout B (1995). The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol 41: 132 - 140.
32. Ward AC (1996). Neurovirulence of influenza A virus. J Neuro Virol 2: 139 - 151.
33. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993). Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33: 576 - 582.
34. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83: 7089 - 7093.
35. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD (1997). In vivo compartmentalization of human immunodeficiency virus: evidence from examination of pol sequences from autopsy tissues. J Virol 71: 2059 - 2071.